Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
01/05/2025
Leerink Partners: Downgrades Regulus Therapeutics (RGLS.US) from outperform to market perform, with a target price of $7.00.
Latest
2 m ago
The Yangtze River Delta Railway is expected to transport 4.2 million passengers today, potentially setting a new record for single-day passenger volume.
4 m ago
Why can't the iPhone be manufactured in the US? Global supply chains are difficult to relocate.
6 m ago
In April, the number of second-hand residential properties signed in Guangzhou exceeded 10,000 units.
6 m ago
Guangzhou: In the first quarter of 2025, a total of 677 new industrial investment projects were signed, with an expected total investment of 227.49 billion yuan.
8 m ago
Guangzhou exhibition companies intend to achieve over 2 billion USD in deals.
See all latest